VIable

Recommendations

Info

NDHI NAT IONAL DIALOGUE FOR Healthcare Innovation Healthcare Innovation That Supports Clinical Process Improvement Organization Overview C. R. Bard, Inc. (BARD) is a multinational developer, manufacturer and marketer of innovative medical devices focused primarily in the areas of Vascular, Urology, Oncology and Surgical Specialties. BARD is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall healthcare costs. BARD holds itself to the highest ethical standards to assign measurable, robust, clinical and economic value to healthcare and to deliver safe and effective products and programs. Background As ‘Value’ has become paramount to healthcare providers in this era of accountable care delivery, healthcare providers are faced with increasing operational costs while patients are presenting with more risk factors. The balance of cost and outcomes involves addressing key challenges in controlling procedural complications such as infection, radiation exposure, and variation in treatment protocols, often in addition to sub-optimal product use or selection. There needs to be a focus on using the right product for the right patient at the right cost. Product Details Even though hospitals educate on proper techniques, clinical management practices often vary, potentially resulting in less than optimal outcomes. Product selection standardization, a key component of procedural standardization, can help clinicians as they seek to achieve optimal product performance, use and outcomes. BARD is helping reinforce the importance of procedural standardization in many ways. One example is through the introduction of the BARD SURESTEP Foley Catheter Tray. This is an integrated system of product labeling that guides the clinician through product selection and use, which encompasses foley catheter insertion as well as the care and maintenance of these devices. BARD has also developed products that offer unique clinical advantages coupled with process improvement programs. Take, for example, the GEOALIGN ® Marking system, which can be used as an alignment tool during repeat catheterization procedures. The GEOALIGN ® Marking system is designed to accurately align the device at the target lesions, thus helping with procedural efficiency to reduce fluoroscopy time and any associated radiation exposure to both patients and clinicians. An Initiative of the 51 | Healthcare Innovation That Supports Clinical Process Improvement
NDHI NAT IONAL DIALOGUE FOR Healthcare Innovation Other programs, such as the BARD All Points training program, enables BARD through the use of Six-Sigma principles to train hospital staff on proper instructions for product use to support standardization of hospital protocols. This empowers clinicians in their efforts toward safe and effective central line care, and helps to address the costly issue of central line-associated bloodstream infection. The introduction of the SITE~RITE 8 Ultrasound System, with PINPOINT GT Technology provides virtual visualization and navigation of an introducer needle during the needle insertion process into a targeted vein. The SHERLOCK 3CG ® Diamond Tip Confirmation System integrated on the SITE~RITE 8 Ultrasound System aids in the bedside placement of Peripherally Inserted Central Catheters (PICCs), and gives the ability for hospitals to move away from confirmatory x-rays in adult patients with normal cardiac rhythm—protecting patients and healthcare providers from unnecessary radiation. BARD also provides clinical and financial programs, economic models, case studies, value dossiers of research studies, along with validation and data analytics, all of which underscore BARD’s commitment to deliver innovative opportunities and uncover best practices. Value Delivered BARD believes that collaboration with healthcare professionals to provide advanced training, appropriate product selection and use, can impact clinical and economic outcomes in areas such as infection rates, length of stay, product acquisition costs, safety for patients and care givers, and standardization of procedural care. BARD works closely with hospitals and healthcare systems to meet the challenges facing the healthcare arena today. Path Forward BARD’s focus for the future is expanding upon a collaborative emphasis and approach to earlier disease detection and treatment, ultimately improving clinical, economic and patient outcomes. The methodology for BARD’s initiative is evidence-based research that encompasses finding, evaluating, and translating scientific data into usable value analysis information. BARD’s leadership position in its chosen disease states and the quality and breadth of products, enable BARD to partner with suppliers and healthcare providers to reduce healthcare costs, while maintaining superior product quality for the highest level of patient care available. Healthcare Innovation That Supports Clinical Process Improvement | 52
Page 1:
VIable Solutions Private Sector Pro
Page 4 and 5:
Contents Foreword .................
Page 6 and 7: Foreword The U.S. healthcare indust
Page 9 and 10: Section 1 Collaborations to Enable
Page 11 and 12: NDHI NAT IONAL DIALOGUE FOR Healthc
Page 47: NDHI NAT IONAL DIALOGUE FOR Healthc
Page 93: NDHI NAT IONAL DIALOGUE FOR Healthc
Page 99 and 100: Section 3 Policy Reform to Shape th
Page 107 and 108:
NDHI NAT IONAL DIALOGUE FOR Healthc
Page 109 and 110:
Page 111 and 112:
Page 113:
Page 116:
show all

VIable

Create successful ePaper yourself

Delete template?

Save as template?